PL370763A1 - Pochodne 2-indanyloaminowe do leczenia bólu przewlekłego - Google Patents

Pochodne 2-indanyloaminowe do leczenia bólu przewlekłego

Info

Publication number: PL370763A1
Authority: PL; Poland
Prior art keywords: indanylamino; derivatives; chronic pain; therapy; pain
Prior art date: 2001-12-21

Application number

PL02370763A

Other languages

English (en)

Other versions

PL207015B1 (pl

Inventor

Claudio Pietra

Gino Villetti

Original Assignee

Chiesi Farmaceutici S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-21

Filing date

2002-12-06

Publication date

2005-05-30

2002-12-06 Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.

2005-05-30 Publication of PL370763A1 publication Critical patent/PL370763A1/pl

2010-10-29 Publication of PL207015B1 publication Critical patent/PL207015B1/pl

Links

208000002193 Pain Diseases 0.000 title abstract 3
-1 2-indanylamino Chemical class 0.000 title abstract 2
208000000094 Chronic Pain Diseases 0.000 title abstract 2
238000002560 therapeutic procedure Methods 0.000 title 1
241000725303 Human immunodeficiency virus Species 0.000 abstract 2
208000032131 Diabetic Neuropathies Diseases 0.000 abstract 1
206010036376 Postherpetic Neuralgia Diseases 0.000 abstract 1
230000006378 damage Effects 0.000 abstract 1
MNLULKBKWKTZPE-UHFFFAOYSA-N indantadol Chemical compound C1=CC=C2CC(NCC(=O)N)CC2=C1 MNLULKBKWKTZPE-UHFFFAOYSA-N 0.000 abstract 1
210000005036 nerve Anatomy 0.000 abstract 1
208000004296 neuralgia Diseases 0.000 abstract 1
208000021722 neuropathic pain Diseases 0.000 abstract 1
206010044652 trigeminal neuralgia Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL370763A 2001-12-21 2002-12-06 Zastosowanie pochodnych 2-indanyloaminowych do wytwarzania leku do leczenia bólu PL207015B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP01130638A EP1321139B1 (en)	2001-12-21	2001-12-21	2-Indanylamino deratives for the therapy of chronic, acute or inflammatory pain

Publications (2)

Publication Number	Publication Date
PL370763A1 true PL370763A1 (pl)	2005-05-30
PL207015B1 PL207015B1 (pl)	2010-10-29

Family

ID=8179649

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL370763A PL207015B1 (pl)	2001-12-21	2002-12-06	Zastosowanie pochodnych 2-indanyloaminowych do wytwarzania leku do leczenia bólu

Country Status (18)

Country	Link
US (1)	US20050222266A1 (pl)
EP (2)	EP1321139B1 (pl)
JP (1)	JP4427329B2 (pl)
AT (1)	ATE336990T1 (pl)
BR (1)	BR0207371A (pl)
CA (1)	CA2470990C (pl)
DE (1)	DE60122541T2 (pl)
DK (1)	DK1321139T3 (pl)
ES (1)	ES2270947T3 (pl)
HU (1)	HUP0402664A3 (pl)
MX (1)	MXPA04005884A (pl)
NO (1)	NO20033670L (pl)
NZ (1)	NZ533537A (pl)
PL (1)	PL207015B1 (pl)
PT (1)	PT1321139E (pl)
SI (1)	SI1321139T1 (pl)
WO (1)	WO2003053429A2 (pl)
ZA (1)	ZA200404845B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080287480A1 (en) *	2005-07-28	2008-11-20	Chiesi Farmaceutici S.P.A.	Therapeutic Combination Comprising a Nmda Receptors Blocker and a Narcotic Analgesic Substance
MX386293B (es)	2011-02-18	2025-03-18	Libertas Bio Inc	Compuestos de aminoindano y su uso en el tratamiento del dolor.
WO2014028675A1 (en)	2012-08-15	2014-02-20	Endo Pharmaceuticals Inc.	Use of aminoindane compounds in treating overactive bladder and interstitial cystitis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2115792C (en) *	1993-03-05	2005-11-01	David J. Mayer	Method for the treatment of pain
IT1283489B1 (it) *	1996-07-23	1998-04-21	Chiesi Farma Spa	Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
CA2289190A1 (en) *	1997-05-07	1998-11-12	Algos Pharmaceutical Corporation	Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain
ES2267546T3 (es) *	1999-06-10	2007-03-16	Bridge Pharma, Inc.	Agentes anestesicos dermicos.

2001
- 2001-12-21 PT PT01130638T patent/PT1321139E/pt unknown
- 2001-12-21 DK DK01130638T patent/DK1321139T3/da active
- 2001-12-21 EP EP01130638A patent/EP1321139B1/en not_active Expired - Lifetime
- 2001-12-21 SI SI200130651T patent/SI1321139T1/sl unknown
- 2001-12-21 ES ES01130638T patent/ES2270947T3/es not_active Expired - Lifetime
- 2001-12-21 DE DE60122541T patent/DE60122541T2/de not_active Expired - Lifetime
- 2001-12-21 AT AT01130638T patent/ATE336990T1/de active
2002
- 2002-12-06 NZ NZ533537A patent/NZ533537A/en not_active IP Right Cessation
- 2002-12-06 MX MXPA04005884A patent/MXPA04005884A/es active IP Right Grant
- 2002-12-06 CA CA2470990A patent/CA2470990C/en not_active Expired - Fee Related
- 2002-12-06 BR BR0207371-4A patent/BR0207371A/pt not_active IP Right Cessation
- 2002-12-06 EP EP02790474A patent/EP1455771B1/en not_active Expired - Lifetime
- 2002-12-06 US US10/498,350 patent/US20050222266A1/en not_active Abandoned
- 2002-12-06 PL PL370763A patent/PL207015B1/pl not_active IP Right Cessation
- 2002-12-06 HU HU0402664A patent/HUP0402664A3/hu unknown
- 2002-12-06 JP JP2003554186A patent/JP4427329B2/ja not_active Expired - Fee Related
- 2002-12-06 WO PCT/EP2002/013839 patent/WO2003053429A2/en not_active Ceased
2003
- 2003-08-19 NO NO20033670A patent/NO20033670L/no not_active Application Discontinuation
2004
- 2004-06-18 ZA ZA200404845A patent/ZA200404845B/en unknown

Also Published As

Publication number	Publication date
EP1321139B1 (en)	2006-08-23
JP4427329B2 (ja)	2010-03-03
PL207015B1 (pl)	2010-10-29
NO20033670L (no)	2003-10-21
WO2003053429A3 (en)	2003-07-31
HUP0402664A2 (hu)	2005-04-28
DE60122541D1 (de)	2006-10-05
JP2005513101A (ja)	2005-05-12
DE60122541T2 (de)	2007-09-13
WO2003053429A2 (en)	2003-07-03
HUP0402664A3 (en)	2012-05-29
NO20033670D0 (no)	2003-08-19
CA2470990C (en)	2011-03-29
DK1321139T3 (da)	2007-01-02
PT1321139E (pt)	2007-01-31
EP1455771A2 (en)	2004-09-15
EP1321139A1 (en)	2003-06-25
MXPA04005884A (es)	2004-11-01
SI1321139T1 (sl)	2007-02-28
ATE336990T1 (de)	2006-09-15
BR0207371A (pt)	2004-02-10
US20050222266A1 (en)	2005-10-06
CA2470990A1 (en)	2003-07-03
ZA200404845B (en)	2006-07-26
NZ533537A (en)	2006-08-31
ES2270947T3 (es)	2007-04-16
AU2002366727A1 (en)	2003-07-09
EP1455771B1 (en)	2006-11-08

Similar Documents

Publication	Publication Date	Title
WO2003101397A3 (en)	2004-08-26	Tetravalent dengue vaccines
DE60323077D1 (de)	2008-10-02	Immobilisierung und stabilisierung von viren
MY176938A (en)	2020-08-27	3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo[4,5-d] pyrimidin-2-one compounds and prodrugs thereof
DE50203788D1 (de)	2005-09-01	Pharmazeutische zusammensetzung zur ophtalmologischen und rhinologischen anwendung
DE602004032522D1 (de)	2011-06-16	Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung
MXPA03006855A (es)	2004-03-12	Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol, utilizando acido 3,5-diyodotiropropionico, y metodo para su preparacion.
WO2004004757A8 (en)	2004-10-07	Treatment for eye disorder
CY1108401T1 (el)	2014-02-12	Παραγωγα πυρρολοϊμιδαζολης, η παρασκευη τους, φαρμακευτικες συνθεσεις που τα περιεχουν και η χρηση τους ως νοοτροπικων παραγοντων
WO2007035957A3 (en)	2007-09-07	Methods for treating viral infections using polyamine analogs
EA200200502A1 (ru)	2002-10-31	Способ введения ингибитора фосфодиэстеразы 4
PL370763A1 (pl)	2005-05-30	Pochodne 2-indanyloaminowe do leczenia bólu przewlekłego
ATE372774T1 (de)	2007-09-15	Medikament zur verabreichung von amifostin und verwandten wirkstoffen
EA200500774A1 (ru)	2005-12-29	Новая синергетическая комбинация, включающая рофлумиласт и формотерол
WO2024197216A3 (en)	2025-02-06	Mdm2 degraders and uses thereof
ZA200708539B (en)	2008-11-26	Methods of applying ionization radiation for therapy of HIV infection
AU2002234644A1 (en)	2002-09-12	Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
BR0211533A (pt)	2004-07-13	Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas
DE60327249D1 (de)	2009-05-28	Anthranilsäureamide und ihre pharmazeutische verwendung
WO2005072091A3 (en)	2005-12-29	Methods for inhibiting hiv and other viral infections by modulating ceramide metabolism
DE60002172D1 (de)	2003-05-22	Verwendung von (1r,4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopenten-1-methanol in hbv
AU2001276323A1 (en)	2002-02-13	Use of n-oleoylethanolamine for treating psoriasis
BR0211522A (pt)	2004-09-14	Tratamento de dor crÈnica com 3-arilóxi-3-fenilpropanaminas
WO2002030514A3 (en)	2003-07-31	Insulin receptor activators for the treatment of metabolic disorders in humans resulting from treatment of hiv infection with hiv protease inhibitors
MX2007004040A (es)	2007-05-24	Uso para alfa-simpatomimeticos con estructura de 2-imidazolina.
MXPA03010920A (es)	2004-02-27	Uso de alconil l- carnitina para preparacion de medicamento para tratar anhedonia.

Legal Events

Date	Code	Title	Description
2013-02-28	LAPS	Decisions on the lapse of the protection rights	Effective date: 20111206